Heyholder

This is an amended filing

‹ Back to the disclosure you were reading

BLUEMTEC CO., LTD. [Amended] Material Event Report

BLUEMTEC CO., LTD.

AI summary · Not investment advice

Bluemtec corrected its KRW 36.0 billion Series 2 convertible bond filing, changing the bond name, put dates and the underwriter to KDBI Healthcare Value-up LLC.

Total face value

KRW 36.0 billion

Key facts

Working capital
KRW 31.0 billion
Debt repayment
KRW 5.0 billion
% of total shares
32.88%
Conversion price per share
KRW 3,235
Conversion period
Nov 7, 2027 – Oct 6, 2033
Coupon rate
0.0%
Bond type
Series 2 bearer-form unsecured private convertible bondChanged from registered to bearer form by correction
Yield to maturity
0.0%
Maturity date
Nov 6, 2033
Subscriber
KRW 36.0 billionKDBI Healthcare Value-up LLC, assumed underwriter position on Oct 30, 2026
Payment date
Nov 6, 2026
Board resolution date
Oct 8, 2026

Commentary

AI commentary · Not investment advice

What happened

Blue M-Tech is issuing KRW 36.0 billion of Series 2 registered, unsecured, privately placed convertible bonds. The board resolved on 2026.10.08, and the payment date is 2026.11.06. The proceeds are for operating funds of KRW 31.0 billion and debt repayment of KRW 5.0 billion. This filing is a correction, and the subscriber has changed to KDBI Healthcare Value-Up. It was received on 2026.10.30.

In the company's terms

Relative to the company, the issue size is 52.0% of market capitalization. The coupon rate and the yield at maturity are both 0.0%, and the bonds mature on 2033.11.06.

What changes for shareholders

For shareholders, the conversion terms matter. The conversion price is KRW 3,235, and the number of shares that can be issued on conversion is 11,128,284, which is 32.88% of total shares. The conversion request period runs from 2027.11.07 to 2033.10.06.

Earlier Material Event Report filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.03Material Event Report468,541 shares · Early termination after completing treasury share purchases

Comments

No comments yet

Comments from shareholders will appear here.